Detail
| LncRNA Name | LINC00161 |
| Synonyms | LINC00161, C21orf100 |
| Region | GRCh38_21:28539318-28540355 Sequence |
| Ensembl | ENSG00000226935 |
| RefSeq | NR_026552 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 M8170/3 |
| Methods | qPCR, in vitro knockdown etc. |
| Sample | hepatocellular carcinoma tissues, cell lines (HepG2, Hep3B, Huh7 and SMMC7721) |
| Expression Pattern | up-regulated |
| Function Description | The result showed that the expression level of LINC00161 was significantly higher in HCC tissues. Further analysis indicated that HCC patients with higher LINC00161 expression have shorter survival. |
| Pubmed ID | 28915581 |
| Year | 2017 |
| Title | Up-regulation of LINC00161 correlates with tumor migration and invasion and poor prognosis of patients with hepatocellular carcinoma |
| External Links |
| Links for LINC00161 | GenBank HGNC lncrnadb Noncode |
| Links for hepatocellular carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.